Advances in Genitourinary Tumor Genomics and Immunotherapy

Area of Science:

• Immunology
• Bioengineering
• Data Science

Background:

• Cancer immunotherapy relies on understanding and manipulating the immune system.
• Accurate immune monitoring is essential for predicting treatment success and tailoring therapies.

Purpose of the Study:

• To provide a comprehensive review of current and emerging immune monitoring and modulation technologies in cancer immunotherapy.
• To analyze the strengths, limitations, and future directions of these advancements.

Main Methods:

• Review of current immune monitoring techniques (e.g., flow cytometry, single-cell RNA sequencing, multiplex cytokine profiling).
• Exploration of novel immune modulation strategies (e.g., biomaterials, engineered cell therapies).
• Comparative analysis of existing and emerging technological platforms.

Main Results:

• Current technologies enable detailed assessment of patient-specific immune responses.
• Emerging methods offer enhanced immune cell activation and targeted therapeutic delivery.
• Personalized therapies, real-time monitoring, and AI are key future drivers.

Conclusions:

• Integrating immunology, bioengineering, and data science is crucial for advancing cancer immunotherapy.
• Further progress is needed to enhance the precision, safety, and accessibility of immune-based cancer treatments.